
The predictive value of insomnia for the treatment outcome of pharmacotherapy, psychotherapy, and combined therapy in major depressive disorder: A mega-analysis of five randomised clinical trials
PsiquiatriaResumo original em inglês
O que aconteceu
Insomnia represents a common sleep disorder in major depressive disorder (MDD) that is associated with unfavourable treatment outcomes. Yet, it is unknown whether this relationship varies between treatment modalities. The present study aimed to evaluate the predictive value of insomnia for remission status following pharmacotherapy, psychotherapy, and combined therapy.
Data were obtained from five randomised clinical trials investigating the efficacy of MDD treatment in a homogeneous study population. Patients with MDD (N = 898) aged between 18 and 65 years were assessed for insomnia (item score ≥ 2) and remission (total score ≤ 7) using the Hamilton depression rating scale (HDRS-17). Logistic regression analyses were performed to evaluate and compare the predictive value of pre-treatment insomnia for remission status following 24 weeks of treatment while controlling for sex, age, and baseline depression severity.
O que encontraram
Insomnia was associated with significantly lower odds of remission overall (OR = 0.618, 95%CI [0.450-0.849]) as well as for pharmacotherapy (OR = 0.219, 95%CI [0.069-0.692]) and combined therapy (OR = 0.583, 95%CI [0.348-0.976]) but not for psychotherapy. The predictive value was, however, not significantly different between the treatment modalities even though direct comparisons revealed significantly higher odds of remission following psychotherapy compared to pharmacotherapy in the insomnia relative to the control group (OR = 3.414, 95%CI [1.013-11.505]).
Por que isso importa
Insomnia is associated with a decreased likelihood of remission in MDD. The most profound impact is observed for pharmacotherapy and combined therapy whereas the clinical relevance for psychotherapy appears modest.
Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.
O estudo original
The predictive value of insomnia for the treatment outcome of pharmacotherapy, psychotherapy, and combined therapy in major depressive disorder: A mega-analysis of five randomised clinical trials
Jens H van Dalfsen, Jeanine Kamphuis, Cagdas Türkmen, Jaap Peen, Sanne H Booij, Katja P van Oosterzee, Harriëtte Riese, Jack J M Dekker, Robert A Schoevers
Descritores MeSH
- Psychotherapy
- Sleep Initiation and Maintenance Disorders
- Antidepressive Agents
- Major Depressive Disorder
- Female
- Humans
- Male
- Middle Aged
- Randomized Controlled Trials as Topic
- Treatment Outcome
Veja também
Estudos relacionados
- Efficacy of antidepressants in addition to psychotherapy in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials
- Effectiveness of ketamine-assisted psychotherapy as a treatment for treatment-resistant depression: a systematic review
- Trajectories and predictors of depressive and anxiety symptom improvement with adjunctive cariprazine in antidepressant-treated adults with major depression: A Bayesian mega-analysis of two randomized trials
- Is combined antidepressant medication (ADM) and psychotherapy better than either monotherapy at preventing suicide attempts and other psychiatric serious adverse events for depressed patients? A rare events meta-analysis